Launch of new CBD brand
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.
14 June 2019
Highlands Natural Resources plc
("Highlands" or the "Company")
Launch of new CBD brand
Highlands and its wholly owned subsidiary Zoetic are pleased to announce the launch of their new "Chill" brand and to report that the first shipment of products has been scheduled for the week commencing 17 June 2019.
Chill (www.thechillway.com) is a new range of CBD (cannabidiol) products, initially comprising hemp flower and CBD infused herbal smokables. It will soon be extended to chew pouches. The products will be made available to buy in 18 Schrader Oil convenience and gas stores, as previously announced, with delivery of the first products being made next week. Additionally, the products will be made available to buy in the United States on the Chill website shortly.
As part of Zoetic, Chill will produce CBD products as tobacco alternatives for enthusiasts and smokers. All of its products will be produced from natural sources and will be manufactured in Colorado. With the exception of the hemp flower smokables, Chill's CBD products will have zero THC (tetrahydrocannabinol) and will be third party tested to make sure they are free of contaminants.
Zoetic continues to develop at a rapid rate and the Company anticipates launching its second brand and additional products in the coming weeks.
Robert Price, Executive Chairman and CEO of Highlands, said: "To make delivery of our first products for retail within three months of commencing operations is an extraordinary achievement and is testament to the hard work of all of the team at Highlands and Zoetic. We are optimistic about our early sales and will update investors in due course."
Highlands Natural Resources plc +1 (0) 303 322 1066
Cantor Fitzgerald Europe +44 (0) 20 7894 7000
Newgate Communications +44 (0) 20 3757 6880
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE